What Does a VUS Result Mean in Morquio Syndrome Testing?
At a Glance
A Variant of Uncertain Significance (VUS) on a Morquio syndrome genetic test means a DNA change was found, but it is unclear if it causes the disease. To confirm a diagnosis, doctors will order secondary tests like enzyme activity assays to measure how the body is functioning.
When a child’s genetic test results come back showing a Variant of Uncertain Significance (VUS), it can be incredibly confusing and anxiety-inducing for parents. Simply put, a VUS means that a change (mutation) was found in your child’s DNA, but there is not yet enough medical evidence to know if this specific change causes Morquio syndrome or if it is just a harmless variation [1][2]. Morquio syndrome (Mucopolysaccharidosis type IV) is an autosomal recessive condition, meaning a child must inherit two non-working copies of the gene to have the disease. Because Morquio syndrome is so rare, doctors frequently encounter genetic changes in the associated genes (GALNS for Morquio A and GLB1 for Morquio B) that have not been studied or documented enough to classify as clearly disease-causing (pathogenic) or harmless (benign) [3][4].
A VUS on a genetic test does not automatically mean your child has Morquio syndrome, nor does it rule it out. Instead, it signals to your medical team that they need to look beyond the DNA sequence to establish a definitive clinical diagnosis. Genetics are just one piece of the puzzle.
Moving Beyond Genetics: Secondary Testing
When a genetic test is ambiguous, geneticists and metabolic specialists rely heavily on biochemical testing to clarify the situation. These tests look at how the body is actually functioning, rather than just reading the genetic blueprint.
Enzyme Activity Assays
This is considered the gold standard for diagnosing Morquio syndrome. Morquio A is caused by a deficiency of the GALNS enzyme, and Morquio B is caused by a deficiency of the GLB1 enzyme [5][6]. Doctors can measure the activity of these enzymes in white blood cells (leukocytes) or skin cells (fibroblasts). If your child’s enzyme activity is significantly lower than normal, it provides strong evidence that the VUS is indeed causing the disease, allowing doctors to confirm the diagnosis even if the genetic test remains uncertain [3][7]. A confirmed clinical diagnosis based on these low enzyme levels and physical symptoms often allows doctors to proceed with treatment options, such as Enzyme Replacement Therapy (ERT) for Morquio A, without waiting for the VUS to be reclassified.
Urine GAG and Biomarker Levels
People with Morquio syndrome lack the enzymes needed to break down certain complex sugars called glycosaminoglycans (GAGs), specifically keratan sulfate (KS) and chondroitin-6-sulfate (C6S), leading to their buildup in the body and elimination in urine [5][8]. Your doctor may order a urine test to measure GAG levels. However, it is important to know that total urine GAG levels can sometimes appear normal in patients with Morquio syndrome, which means a normal result does not completely rule out the disease [9][4]. Because of this, doctors often prefer looking specifically at keratan sulfate levels or moving directly to enzyme activity testing [9][4].
What Happens Next?
If your child receives a VUS, the clinical care team will take an integrated approach to solve the diagnostic puzzle:
- Correlating Symptoms: They will closely evaluate whether your child’s physical symptoms and imaging match the expected signs of Morquio syndrome [8][3]. This includes looking for specific bone changes on X-rays (called dysostosis multiplex), which may show up as short stature, a prominent chest, or knock-knees.
- Family Testing: Doctors will often test both parents (a process called segregation analysis). Because Morquio is an autosomal recessive disease, a child must inherit one disease-causing genetic change from each parent. Finding the VUS in one parent and a different pathogenic variant in the other helps confirm the diagnosis, as healthy parents are typically carriers who have one working gene and one non-working gene [1][10].
- Re-evaluation over Time: As more children are genetically tested globally, databases grow. A variant that is a VUS today may be reclassified as pathogenic or benign in the future as more data is collected [1][10]. It is highly recommended that you proactively follow up with your genetic counselor or specialist every 1-2 years to ask if there are any updates, as clinics do not always notify families automatically.
While waiting for answers is difficult, these secondary evaluations give your medical team concrete ways to piece together a definitive diagnosis and begin building a comprehensive care plan.
Common questions in this guide
Does a VUS mean my child has Morquio syndrome?
What is the next step after getting a VUS result for Morquio syndrome?
Why might my doctor test my partner and me if my child has a VUS?
Can my child start Enzyme Replacement Therapy (ERT) if their genetic test shows a VUS?
Will a VUS ever be reclassified?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has my child had a specific enzyme activity assay (GALNS or GLB1), and what were the exact results?
- 2.Did our urine tests look specifically for keratan sulfate, or was it just a general GAG screening?
- 3.What is the process for testing my partner and me to see how my child inherited this genetic variant?
- 4.If the enzyme assay and clinical symptoms point to Morquio syndrome, can we begin treatment planning even if the genetic test is still a VUS?
- 5.How frequently should I check back with your office regarding updates or reclassification of my child's VUS?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (10)
- 1
Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum.
Postel MD, Culver JO, Ricker C, Craig DW
Human mutation 2022; (43(11)):1590-1608 doi:10.1002/humu.24394.
PMID: 35510381 - 2
Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients.
Henkel J, Laner A, Locher M, et al.
European journal of human genetics : EJHG 2023; (31(8)):925-930 doi:10.1038/s41431-023-01380-2.
PMID: 37188824 - 3
A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
Kim SM, Noh ES, Park JH, et al.
Annals of human genetics 2022; (86(6)):361-368 doi:10.1111/ahg.12483.
PMID: 36000290 - 4
Atypical presentation of mucopolysaccharidosis type IVA.
Rush ET
Molecular genetics and metabolism reports 2016; (8()):8-12 doi:10.1016/j.ymgmr.2016.05.006.
PMID: 27331011 - 5
Voice alterations in patients with Morquio A syndrome.
Szklanny K, Gubrynowicz R, Tylki-Szymańska A
Journal of applied genetics 2018; (59(1)):73-80 doi:10.1007/s13353-017-0421-6.
PMID: 29275451 - 6
Novel data on growth phenotype and causative genotypes in 29 patients with Morquio (Morquio-Brailsford) syndrome from Central-Eastern Europe.
Jezela-Stanek A, Różdżyńska-Świątkowska A, Kulpanovich A, et al.
Journal of applied genetics 2019; (60(2)):163-174 doi:10.1007/s13353-019-00491-1.
PMID: 30927141 - 7
Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity.
Shams S, Barazandeh Tehrani M, Civallero G, et al.
Journal of diabetes and metabolic disorders 2017; (16()):37 doi:10.1186/s40200-017-0319-1.
PMID: 28904929 - 8
Efficacy of Intravenous Elosulfase Alfa for Mucopolysaccharidosis Type IVA: A Systematic Review and Meta-Analysis.
Lee CL, Chuang CK, Syu YM, et al.
Journal of personalized medicine 2022; (12(8)) doi:10.3390/jpm12081338.
PMID: 36013287 - 9
Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA.
Chin SJ, Saville JT, McDermott BK, et al.
JIMD reports 2020; (55(1)):68-74 doi:10.1002/jmd2.12132.
PMID: 32905071 - 10
Variant reclassification and clinical implications.
Walsh N, Cooper A, Dockery A, O'Byrne JJ
Journal of medical genetics 2024; (61(3)):207-211 doi:10.1136/jmg-2023-109488.
PMID: 38296635
This page explains genetic testing terms for educational purposes. Always consult your geneticist or metabolic specialist to interpret your child's specific lab results.
Get notified when new evidence is published on Mucopolysaccharidosis type 4.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.